Detalhe da pesquisa
1.
Radiotherapy-assisted tumor selective metronomic oral chemotherapy.
Int J Cancer
; 141(9): 1912-1920, 2017 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28635011
2.
Safety studies on intravenous infusion of a potent angiogenesis inhibitor: taurocholate-conjugated low molecular weight heparin derivative LHT7 in preclinical models.
Drug Dev Ind Pharm
; 42(8): 1247-57, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26612099
3.
Enhanced Anti-Angiogenic Effect of Low Molecular Weight Heparin-Bile Acid Conjugates by Co-Administration of a Selective COX-2 Inhibitor.
Pharm Res
; 32(7): 2318-27, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25585956
4.
Preliminary safety evaluation of a taurocholate-conjugated low-molecular-weight heparin derivative (LHT7): a potent angiogenesis inhibitor.
J Appl Toxicol
; 35(1): 104-15, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24532548
5.
Combinational chemoprevention effect of celecoxib and an oral antiangiogenic LHD4 on colorectal carcinogenesis in mice.
Anticancer Drugs
; 25(9): 1061-71, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25003253
6.
Stimulating macropinocytosis of peptide-drug conjugates through DNA-dependent protein kinase inhibition for treating KRAS-mutant cancer.
J Control Release
; 2024 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38880331
7.
Nanofiber-based glaucoma drainage implant improves surgical outcomes by modulating fibroblast behavior.
Bioeng Transl Med
; 8(3): e10487, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37206200
8.
Caspase-3 mediated switch therapy of self-triggered and long-acting prodrugs for metastatic TNBC.
J Control Release
; 346: 136-147, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35447298
9.
Metronomic dose-finding approach in oral chemotherapy by experimentally-driven integrative mathematical modeling.
Biomaterials
; 286: 121584, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35617783
10.
Feedback amplification of senolysis using caspase-3-cleavable peptide-doxorubicin conjugate and 2DG.
J Control Release
; 346: 158-168, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35452763
11.
Albumin metabolism targeted peptide-drug conjugate strategy for targeting pan-KRAS mutant cancer.
J Control Release
; 344: 26-38, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35202743
12.
Targeting angiogenic growth factors using therapeutic glycosaminoglycans on doppel-expressing endothelial cells for blocking angiogenic signaling in cancer.
Biomaterials
; 283: 121423, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35220018
13.
Sustained potentiation of bystander killing via PTEN-loss driven macropinocytosis targeted peptide-drug conjugate therapy in metastatic triple-negative breast cancer.
Biomaterials
; 289: 121783, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36084486
14.
Overcoming physical stromal barriers to cancer immunotherapy.
Drug Deliv Transl Res
; 11(6): 2430-2447, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34351575
15.
Keratin 19 interacts with GSK3ß to regulate its nuclear accumulation and degradation of cyclin D3.
Mol Biol Cell
; 32(21): ar21, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34406791
16.
Caspase-cleavable peptide-doxorubicin conjugate in combination with CD47-antagonizing nanocage therapeutics for immune-mediated elimination of colorectal cancer.
Biomaterials
; 277: 121105, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34478928
17.
Dual mechanistic TRAIL nanocarrier based on PEGylated heparin taurocholate and protamine which exerts both pro-apoptotic and anti-angiogenic effects.
J Control Release
; 336: 181-191, 2021 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34144107
18.
Anticoagulation therapy promotes the tumor immune-microenvironment and potentiates the efficacy of immunotherapy by alleviating hypoxia.
J Immunother Cancer
; 9(8)2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34341129
19.
Polyproline-type helical-structured low-molecular weight heparin (LMWH)-taurocholate conjugate as a new angiogenesis inhibitor.
Int J Cancer
; 124(12): 2755-65, 2009 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19243020
20.
Highly potent monomethyl auristatin E prodrug activated by caspase-3 for the chemoradiotherapy of triple-negative breast cancer.
Biomaterials
; 192: 109-117, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30447398